Literature DB >> 8376820

Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients.

V Schauf1, W N Rom, K A Smith, E P Sampaio, P A Meyn, J M Tramontana, Z A Cohn, G Kaplan.   

Abstract

Selected parameters of cellular immunity relating to cytokine gene activation and responsiveness to interleukin-2 (IL-2) were analyzed in 27 patients with active pulmonary tuberculosis and no human immunodeficiency virus type 1 infection. Cytokine mRNAs were not expressed by peripheral blood mononuclear cells (PBMC) of normal controls. In PBMC of tuberculosis patients, messages for IL-1, IL-8, and tumor necrosis factor-alpha were uniformly expressed, whereas PBMC of only 5 of 18 patients expressed IL-6. PBMC of 7 patients (all of those with systemic symptoms) expressed interferon-gamma mRNA and none expressed IL-2 mRNA. Most patients' cells demonstrated IL-4 mRNA. Limiting dilution analysis of IL-2-responsive cells in PBMC revealed that tuberculosis patients had 10-fold fewer IL-2-responsive cells than did controls.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376820     DOI: 10.1093/infdis/168.4.1056

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

Review 1.  Intractable mycobacterial infections associated with genetic defects in the receptor for interferon gamma: what does this tell us about immunity to mycobacteria?

Authors:  G A Rook
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139

2.  Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment.

Authors:  A Verbon; N Juffermans; S J Van Deventer; P Speelman; H Van Deutekom; T Van Der Poll
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

3.  Role of QuantiFERON-TB Gold antigen-specific IL-1β in diagnosis of active tuberculosis.

Authors:  Maddineni Prabhavathi; Basirudeen Syed Ahamed Kabeer; Anbarasu Deenadayalan; Alamelu Raja
Journal:  Med Microbiol Immunol       Date:  2014-12-11       Impact factor: 3.402

4.  Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis.

Authors:  C A Evans; J Jellis; S P Hughes; D G Remick; J S Friedland
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

Review 5.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

6.  Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection.

Authors:  R Hernandez-Pando; L Pavön; K Arriaga; H Orozco; V Madrid-Marina; G Rook
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

Review 7.  Cytokines and Chemokines in Mycobacterium tuberculosis Infection.

Authors:  Racquel Domingo-Gonzalez; Oliver Prince; Andrea Cooper; Shabaana A Khader
Journal:  Microbiol Spectr       Date:  2016-10

8.  Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG.

Authors:  R Al-Attiyah; A S Mustafa
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

9.  Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals.

Authors:  E P Sampaio; J R Caneshi; J A Nery; N C Duppre; G M Pereira; L M Vieira; A L Moreira; G Kaplan; E N Sarno
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Gamma/delta T cell subsets in patients with active Mycobacterium tuberculosis infection and tuberculin anergy.

Authors:  L Szereday; Z Baliko; J Szekeres-Bartho
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.